Core Center

Chicago, Illinois 60612

0 studies enrolling now · 5 studies all time

What they study most

HIV, HIV Infections, HIV-1 Infection, Medication Adherence, Pre-exposure Prophylaxis

Studies at this site

• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed
• Life Steps for PrEP for Youth — Completed
• Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 — Completed
• Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART — Completed
• Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor — Completed